Invention Grant
- Patent Title: Pharmaceutical formulations of a HIF hydroxylase inhibitor
-
Application No.: US16035503Application Date: 2018-07-13
-
Publication No.: US10765672B2Publication Date: 2020-09-08
- Inventor: David Conca , Lee Allen Flippin , Scott David Leigh , Claudia Witschi , Lee Robert Wright
- Applicant: FibroGen, Inc.
- Applicant Address: US CA San Francisco
- Assignee: FibroGen, Inc.
- Current Assignee: FibroGen, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Sheppard Mullin Richter & Hampton LLP
- Agent Leanne C. Price
- Main IPC: A61K31/472
- IPC: A61K31/472 ; A61K9/28 ; A61K9/48 ; A61K9/20
Abstract:
The present disclosure relates to pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid and methods of use thereof.
Public/Granted literature
- US20190008846A1 PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR Public/Granted day:2019-01-10
Information query
IPC分类:
